(Q42959222)

11 November 2017

title

Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study (English)

1 reference

11 November 2017

1 reference

1 reference

8

Takashi Kojima

1 reference

11 November 2017

3

Narikazu Boku

1 reference

11 November 2017

Takehito Shukuya

1

1 reference

11 November 2017

Hirofumi Yasui

2

1 reference

11 November 2017

Yusuke Onozawa

4

1 reference

11 November 2017

Akira Fukutomi

5

1 reference

11 November 2017

Kentaro Yamazaki

6

1 reference

11 November 2017

Keisei Taku

7

1 reference

11 November 2017

Nozomu Machida

9

1 reference

11 November 2017

publication date

22 July 2010

1 reference

Japanese Journal of Clinical Oncology

11 November 2017

published in

1 reference

11 November 2017

volume

40

1 reference

11 November 2017

issue

12

1 reference

11 November 2017

page(s)

1135-1138

1 reference

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ117

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ117

Phase II trial of oral rubitecan in previously treated pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ117

Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ117

Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ117

Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 960

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYQ117

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYQ117

1 reference

11 November 2017

1 reference